UnitedHealthcare and Humana to end Medicare Advantage plans for nearly one million seniors

Industry pullback deepens as insurers cut benefits, raise costs and exit less profitable products for 2027

By LineZotpaper
Published
Read Time3 min
The two largest Medicare Advantage (MA) insurers, UnitedHealthcare (UHC) and Humana, are terminating plans covering nearly one million seniors in 2027, according to a Healthcare Brew report. The moves reflect a broader industry retrenchment as payers respond to rising utilisation and medical costs by reducing benefits, shifting enrollees into narrower networks and canceling low-return plans, even as the Centers for Medicare and Medicaid Services describes the market as stable.

Humana Chief Financial Officer Celeste Mellet disclosed during a July earnings call that roughly 600,000 members, about 8 per cent of the company's nearly 7.2 million MA members, will lose their current plan. UnitedHealth Group spokesperson Eric Hausman confirmed that approximately 390,000 members will be affected by UHC's plan closures. Mellet said Humana hopes to "recapture a significant portion" of the displaced members through a "targeted" approach that primarily ends low-return plans while keeping high-return products.

UHC President Bobby Hunter said during the company's third-quarter earnings call that its cuts focused on PPO plans, continuing a yearslong strategy that prioritises health maintenance organization (HMO) and special needs plans (SNPs). Experts told Healthcare Brew that HMOs typically have more limited networks and higher cost-sharing, giving insurers more control over utilisation.

Benefit reductions are not limited to plan exits. An analysis by Leerink Partners of the Medicare Plan Finder found many major carriers cut dental benefits and raised enrollees' cost-sharing for 2027. Clover Health increased its maximum out-of-pocket cost by $1,144 for all sampled members. Jamie Reynoso, CEO of Medicare Advantage at Clover, argued that benefit changes must be viewed in context, telling Healthcare Brew that "looking only at how much the benefits have changed from one year to the next doesn't tell the full story."

The shift extends to standalone Part D drug plans, with 4 million enrollees losing access to $0 premium options available last year. Brooks Conway, a principal at Oliver Wyman, told Healthcare Brew that $0 premium MA products are also disappearing or becoming leaner. "In most regions, for a long period of time, if you wanted to be a competitive Medicare Advantage insurer, you needed a $0 product. In 2026 and continuing into 2027 … you're either seeing no options for a $0 product or the benefits associated with that $0 product becoming leaner," Conway said.

Alexis Levy, senior partner at HealthScape Advisors, warned that even enrollees who keep their plans will likely see reduced coverage. "A senior may be able to keep their plan, but that doesn't mean they're going to have the same level of benefit that they had from the previous year, and in many cases, they may not," Levy said. Forrester Principal Analyst Arielle Trzcinski noted that the industry-wide turn toward SNPs and C-SNPs is accelerating, as these plans allow more active care management and carry higher margins.

§

Analysis

Why This Matters

  • Nearly one million seniors must find new coverage or face higher costs and reduced benefits in 2027.
  • The industry pullback signals a fundamental rebalancing of the Medicare Advantage market from a growth phase to a margin-protection phase.
  • The trend could draw political scrutiny if access and affordability become flashpoints in the broader Medicare debate.

Background

Medicare Advantage has been a fast-growing segment of the US health insurance market, attracting millions of seniors with low premiums and supplemental benefits. A sharp spike in utilisation and medical costs over the past two years has squeezed insurer margins, prompting a broad reassessment. While regulatory signals from CMS have emphasised market stability and lower average premiums, the detailed picture reveals a systematic scaling back of benefits and plan options.

Key Perspectives

Insurers (UHC, Humana, Clover): View the cuts as a necessary response to an unsustainable cost environment, focusing resources on products with stronger margins while arguing that remaining plans continue to offer competitive value. Industry Analysts (Leerink Partners, HealthScape, Oliver Wyman): Describe the trend as a deliberate "prioritization of margin over growth," predicting the pullback will continue as payers refine their geographic and product strategies. Consumer Advocates and Enrollees: Face a complex open enrollment period marked by higher out-of-pocket costs, fewer benefit options, and the disruption of being forced into new plans with less generous terms.

What to Watch

  • Open enrollment results for 2027: whether Humana succeeds in recapturing displaced members and how membership shifts across carriers.
  • Financial reports from UHC and Humana through 2027 to assess whether the strategy restores margins.
  • Any regulatory or congressional response if beneficiary costs and access become a political issue.

Sources

Checked

12 claims in this story checked against 1 source: 4 supported.

Show each claim
  1. Partly supportedUnitedHealthcare and Humana are ending plans for nearly one million seniors in 2027.Fortune | FORTUNE: “The two largest MA providers by enrollment, Humana and UHC, are ending plans impacting a cumulative nearly 1 million people.”
  2. Partly supportedThe industry pullback is deepening as insurers cut benefits, raise costs and exit less profitable products for 2027.Fortune | FORTUNE: “experts told Healthcare Brew that payers are increasing cost-sharing for enrollees, shifting them into narrower networks, and cutting supplemental benefits”
  3. Partly supportedPayers are cutting benefits, narrowing networks and canceling low-return plans in response to rising utilization and medical costs.Fortune | FORTUNE: “experts told Healthcare Brew that payers are increasing cost-sharing for enrollees, shifting them into narrower networks, and cutting supplemental benefits in response to a spike in utilization and medical costs over the last couple years.”
  4. Partly supportedCMS describes the Medicare Advantage market as stable.Fortune | FORTUNE: “The Centers for Medicare and Medicaid Services (CMS) has described MA 2027 plan options as “stable,” with lower average premiums.”
  5. SupportedAbout 600,000 Humana members, roughly 8% of its nearly 7.2 million MA members, will lose their current plan.Fortune | FORTUNE: “About 600,000 people are in a Humana MA plan that is ending in 2027, Humana CFO Celeste Mellet said during a July earnings call, amounting to about 8% of the payer’s nearly 7.2 million MA members.”
  6. SupportedUHC spokesperson Eric Hausman confirmed that about 390,000 members will be affected by plan closures.Fortune | FORTUNE: “Parent company UnitedHealth Group (UHG) spokesperson Eric Hausman confirmed to Healthcare Brew via email that about 390,000 members will be impacted by plan closures.”
  7. SupportedMellet said Humana hopes to “recapture a significant portion” through a “targeted” approach.Fortune | FORTUNE: “Mellet said during the July call that the payer hopes to “recapture a significant portion” of the 600,000 people impacted by plan exits. The company took a “targeted” approach”
  8. Partly supportedExperts told Healthcare Brew that HMOs typically have more limited networks and higher cost-sharing, giving insurers more control over utilization.Fortune | FORTUNE: “Plans are turning to HMOs because they typically have more limited networks and higher cost sharing compared to PPOs, allowing plans to better control utilization, Trzcinski said.”
  9. SupportedClover Health increased its maximum out-of-pocket cost by $1,144 for all sampled members.Fortune | FORTUNE: “Clover’s maximum out-of-pocket cost increased by $1,144 for all sampled members, the most of any represented payer.”
  10. Partly supportedFour million standalone Part D enrollees are losing access to $0 premium options they had last year.Fortune | FORTUNE: “There are also no longer $0 premiums offered to 4 million standalone Part D drug plan enrollees who got them last year, though enrollees who qualify for low-income subsidies may still get $0 premiums”
  11. Partly supportedConway said that in 2026 and continuing into 2027, either there are no $0 product options or “the benefits associated with that $0 product becoming leaner.”Fortune | FORTUNE: ““In 2026 and continuing into 2027…you’re either seeing no options for a $0 product or the benefits that are associated with that $0 product becoming leaner.””
  12. Partly supportedForrester analyst Arielle Trzcinski said the turn toward SNPs and C-SNPs is accelerating, and that these plans allow more active care management and carry higher margins.Fortune | FORTUNE: “SNPs also have higher margins and provide personalized benefits to patients with more intensive needs, arguably allowing for more active care management, she said. Levy said the increase in chronic special needs plans (C-SNPs) is continuing to “ramp up” this year.”

Zotpaper

Written by Harper Lane on the Business & markets desk. Claims checked by Ines Fairley, verification. Edited by Angus Burke, chief sub.

1 source4 of 12 claims matched to a sourcefirst published updated once
Meet the newsroomHow we workSubscribe